Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma

被引：9
|
作者：
Tessier, MH
Pandolfino, MC
Jotereau, F
Boudart, D
Litoux, P
Dreno, B
机构：
[1] CHU NANTES,HOTEL DIEU,DEPT DERMATOL,F-44035 NANTES 01,FRANCE
[2] INSERM,U211,F-44035 NANTES 01,FRANCE
[3] CTR REG TRANSFUS SANGUINE,BLOOD BANK,F-44035 NANTES 01,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 04期
关键词：
D O I：
10.1016/0959-8049(95)00651-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：735 / 736
页数：2
相关论文
共 50 条
  • [21] Repeated immunotherapy using intratumoural injection with recombinant interleukin-2 and tumour-infiltrating lymphocytes inhibits growth of breast cancer and induces apoptosis of tumour cells
    Liu, DL
    Yang, MQ
    Eberhardt, J
    Persson, B
    CANCER LETTERS, 1996, 103 (02) : 131 - 136
  • [22] USE OF TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF PATIENTS WITH METASTATIC MELANOMA - A PRELIMINARY-REPORT
    ROSENBERG, SA
    PACKARD, BS
    AEBERSOLD, PM
    SOLOMON, D
    TOPALIAN, SL
    TOY, ST
    SIMON, P
    LOTZE, MT
    YANG, JC
    SEIPP, CA
    SIMPSON, C
    CARTER, C
    BOCK, S
    SCHWARTZENTRUBER, D
    WEI, JP
    WHITE, DE
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (25): : 1676 - 1680
  • [23] Multispectral imaging for highly accurate analysis of tumour-infiltrating lymphocytes in primary melanoma
    Vasaturo, Angela
    Di Blasio, Stefania
    Verweij, Dagmar
    Blokx, Willeke A. M.
    van Krieken, J. Han
    de Vries, I. Jolanda M.
    Figdor, Carl G.
    HISTOPATHOLOGY, 2017, 70 (04) : 643 - 649
  • [24] Phenotypic and functional analyses of fresh and recombinant interleukin-2 cultured tumour-infiltrating lymphocytes derived from malignant human liver tumours
    Yoong, KF
    Adams, DH
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S271 - S271
  • [25] Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
    Sebastian Klobuch
    Tom T. P. Seijkens
    Ton N. Schumacher
    John B. A. G. Haanen
    Nature Reviews Clinical Oncology, 2024, 21 : 173 - 184
  • [26] THE TREATMENT OF PATIENTS WITH MELANOMA USING INTERLEUKIN-2, INTERLEUKIN-4 AND TUMOR INFILTRATING LYMPHOCYTES
    LOTZE, MT
    HUMAN GENE THERAPY, 1992, 3 (02) : 167 - 177
  • [27] Tumour-infiltrating lymphocyte therapy for patients with advanced-stage melanoma
    Klobuch, Sebastian
    Seijkens, Tom T. P.
    Schumacher, Ton N.
    Haanen, John B. A. G.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (03) : 173 - 184
  • [28] Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma
    M Lotem
    E Shiloni
    I Pappo
    O Drize
    T Hamburger
    R Weitzen
    R Isacson
    L Kaduri
    S Merims
    S Frankenburg
    T Peretz
    British Journal of Cancer, 2004, 90 : 773 - 780
  • [29] Interleukin-2 improves tumour response to DNP-modified autologous vaccine for the treatment of metastatic malignant melanoma
    Lotem, M
    Shiloni, E
    Pappo, I
    Drize, O
    Hamburger, T
    Weitzen, R
    Isacson, R
    Kaduri, L
    Merims, S
    Frankenburg, S
    Peretz, T
    BRITISH JOURNAL OF CANCER, 2004, 90 (04) : 773 - 780
  • [30] Adjuvant adaptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients
    Ridolfi, R
    Flamini, E
    Riccobon, A
    De Paola, F
    Maltoni, R
    Gardini, A
    Ridolfi, L
    Medri, L
    Poletti, G
    Amadori, D
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 46 (04) : 185 - 193
12345